Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.980
+0.030 (1.54%)
Apr 15, 2026, 10:05 AM EDT - Market open
Enveric Biosciences Employees
As of December 31, 2025, Enveric Biosciences had 6 total employees, including 5 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,021,912
Market Cap
3.74M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 6 | 0 | - | 5 | 1 |
| Dec 31, 2024 | 6 | -1 | -14.29% | 5 | 1 |
| Dec 31, 2023 | 7 | -19 | -73.08% | 7 | 0 |
| Dec 31, 2022 | 26 | 2 | 8.33% | 25 | 1 |
| Dec 31, 2021 | 24 | 21 | 700.00% | 23 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| BiomX | 20 |
| GeoVax Labs | 17 |
| Silexion Therapeutics | 14 |
| VivoSim Labs | 14 |
| Azitra | 13 |
| Decoy Therapeutics | 11 |
| Revelation Biosciences | 9 |
ENVB News
- 15 days ago - Enveric Biosciences Secures New U.S. Patent for Its EVM301 Series of Drug Candidates - Business Wire
- 18 days ago - Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025 - Business Wire
- 4 weeks ago - Enveric Biosciences Announces Registration of Five Trademarks - Business Wire
- 7 weeks ago - Enveric Biosciences Announces Withdrawal of Petition Against Its Patent - Business Wire
- 7 weeks ago - Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data - Business Wire
- 2 months ago - Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option - Business Wire
- 2 months ago - Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Business Wire
- 2 months ago - Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Business Wire